H R Maecke
16.05.2008
Radiolabeled DOTATOC in patients with advanced paraganglioma and pheochromocytoma
Forrer F, Riedweg I, Maecke H, Mueller-Brand J. Radiolabeled DOTATOC in patients with advanced paraganglioma and pheochromocytoma. Q J Nucl Med Mol Imaging 2008; 52:334-40.
16.05.2008Radiolabeled DOTATOC in patients with advanced paraganglioma and pheochromocytoma
16.05.2008Q J Nucl Med Mol Imaging 2008; 52:334-40
Forrer Flavio, Riedweg I, Maecke H R, Mueller-Brand J
Weiter
10.06.2004
A comparison of (111)In-DOTATOC and (111)In-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumours
Forrer F, Uusijärvi H, Waldherr C, Cremonesi M, Bernhardt P, Mueller-Brand J, Maecke H. A comparison of (111)In-DOTATOC and (111)In-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumours. Eur J Nucl Med Mol Imaging 2004; 31:1257-62.
10.06.2004A comparison of (111)In-DOTATOC and (111)In-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumours
10.06.2004Eur J Nucl Med Mol Imaging 2004; 31:1257-62
Forrer Flavio, Uusijärvi H, Waldherr C, Cremonesi M, Bernhardt P, Mueller-Brand J, Maecke H R
Weiter